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Multiple sclerosis (MS) is an inflammatory demyelinating disease of the central 
nervous system (CNS) that is a leading non-traumatic cause of disability in young 
adults.  The 18 kDa Translocator Protein (TSPO) is a mitochondrial protein and positron 
emission tomography (PET)-imaging target that is highly upregulated in MS brain lesions 
and may potentially represent both an inflammatory biomarker and a therapeutic target for 
the monitoring and treatment of MS.  However, its pathological significance is not well 
understood. While experimental autoimmune encephalomyelitis (EAE) in the common 
marmoset is a well-established primate model of MS, TSPO expression in this model has not 
yet been studied.  Moreover, the comparison of TSPO expression and PET radioligand signal 
in inflammatory conditions has been limited by the lack of suitable unfixed pathological 
samples for concurrent measurement of protein expression and radioligand-binding.     
In this thesis, I seek to characterize patterns of TSPO expression in fixed CNS tissues 
from EAE marmosets using multiplex immunofluorescence and directly compare TSPO 
protein expression measured by flow cytometry with radioligand-binding signal in the 
peripheral blood of healthy donors and MS patients. Through these studies, I have established 
that marmoset EAE recapitulates temporal and cellular patterns of TSPO expression seen in 
MS, rendering it a suitable model for the study of human disease that may give insight into 
the pathological significance of TSPO in immune dysregulation.  Furthermore, I have found 
TSPO expression in the peripheral blood of MS patients to be significantly increased, 
suggesting TSPO to be a useful peripheral biomarker of CNS disease. However, I found that 
radioligand-binding by second-generation PET radioligand PBR28 is paradoxically decreased 
in the peripheral blood of MS patients, implying that the clinical utility of PBR28 may be 
limited, likely by conformational changes occurring in inflammation.  Collectively, these 
results allow us to better interpret the pathological significance of TSPO expression and 
TSPO-radioligand binding in the CNS and peripheral blood in neuroinflammatory disease. 
